Business
Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference
CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1
About this update from Vor Biopharma Inc.
[{"type":"text","content":"CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference. Wedbush PacGrow Healthcare Conference1x1 Investor Meetings: August 8-9, 2023Location: Lotte Palace Hotel, New York, NY About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Media & InvestorsSarah Spencer +1 [email protected] \nSource: Vor Biopharma","length":2207,"tagName":"div"}]